These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
494 related articles for article (PubMed ID: 32381574)
1. International recommendations on the diagnosis and treatment of acquired hemophilia A. Tiede A; Collins P; Knoebl P; Teitel J; Kessler C; Shima M; Di Minno G; d'Oiron R; Salaj P; Jiménez-Yuste V; Huth-Kühne A; Giangrande P Haematologica; 2020 Jul; 105(7):1791-1801. PubMed ID: 32381574 [TBL] [Abstract][Full Text] [Related]
2. International recommendations on the diagnosis and treatment of patients with acquired hemophilia A. Huth-Kühne A; Baudo F; Collins P; Ingerslev J; Kessler CM; Lévesque H; Castellano ME; Shima M; St-Louis J Haematologica; 2009 Apr; 94(4):566-75. PubMed ID: 19336751 [TBL] [Abstract][Full Text] [Related]
3. Should emicizumab be used in patients with acquired hemophilia A? Tiede A; Kemkes-Matthes B; Knöbl P J Thromb Haemost; 2021 Mar; 19(3):637-644. PubMed ID: 33306259 [TBL] [Abstract][Full Text] [Related]
4. Acquired hemophilia in the patient suffering from rheumatoid arthritis: case report. Drobiecki A; Pasiarski M; Hus I; Sokołowska B; Wątek M Blood Coagul Fibrinolysis; 2013 Dec; 24(8):874-80. PubMed ID: 24042266 [TBL] [Abstract][Full Text] [Related]
5. Diagnostic and prognostic value of factor VIII binding antibodies in acquired hemophilia A: data from the GTH-AH 01/2010 study. Werwitzke S; Geisen U; Nowak-Göttl U; Eichler H; Stephan B; Scholz U; Holstein K; Klamroth R; Knöbl P; Huth-Kühne A; Bomke B; Tiede A J Thromb Haemost; 2016 May; 14(5):940-7. PubMed ID: 26988717 [TBL] [Abstract][Full Text] [Related]
11. Cross-reacting recombinant porcine FVIII inhibitors in patients with acquired haemophilia A. Bowyer A; Shepherd F; Platton S; Guy S; Kitchen S; Maclean R Haemophilia; 2020 Nov; 26(6):1181-1186. PubMed ID: 32997894 [TBL] [Abstract][Full Text] [Related]
12. Treatment of Severe Acquired Haemophilia A with Immunosuppressive Agent: A Case Report of One Patient. Škunca Ž; Peraica AP Coll Antropol; 2016 Jun; 40(2):139-43. PubMed ID: 29139630 [TBL] [Abstract][Full Text] [Related]
13. Management of acquired haemophilia A. Tiede A; Scharf RE; Dobbelstein C; Werwitzke S Hamostaseologie; 2015; 35(4):311-8. PubMed ID: 25564260 [TBL] [Abstract][Full Text] [Related]
14. Acquired hemophilia a: diagnosis, aetiology, clinical spectrum and treatment options. Shetty S; Bhave M; Ghosh K Autoimmun Rev; 2011 Apr; 10(6):311-6. PubMed ID: 21115138 [TBL] [Abstract][Full Text] [Related]
15. Acquired haemophilia: management of bleeds and immune therapy to eradicate autoantibodies. Holme PA; Brosstad F; Tjønnfjord GE Haemophilia; 2005 Sep; 11(5):510-5. PubMed ID: 16128896 [TBL] [Abstract][Full Text] [Related]
16. Acquired haemophilia syndrome: pathophysiology and therapy. Elezović I Srp Arh Celok Lek; 2010 Jan; 138 Suppl 1():64-8. PubMed ID: 20229686 [TBL] [Abstract][Full Text] [Related]
17. Acquired hemophilia: a case report and review of the literature. Mulliez SM; Vantilborgh A; Devreese KM Int J Lab Hematol; 2014 Jun; 36(3):398-407. PubMed ID: 24750687 [TBL] [Abstract][Full Text] [Related]
18. Emicizumab in acquired hemophilia A: pros and cons of a new approach to the prevention and treatment of bleeding. Pasca S; Zanon E; Mannucci PM; Peyvandi F Blood Transfus; 2023 Nov; 21(6):549-556. PubMed ID: 36795341 [TBL] [Abstract][Full Text] [Related]
19. Twelve years of experience of acquired hemophilia A: trials and tribulations in South Australia. Tay L; Duncan E; Singhal D; Al-Qunfoidi R; Coghlan D; Jaksic W; Szabo F; McRae S; Lloyd J Semin Thromb Hemost; 2009 Nov; 35(8):769-77. PubMed ID: 20169513 [TBL] [Abstract][Full Text] [Related]
20. Emicizumab for the treatment of acquired hemophilia A. Knoebl P; Thaler J; Jilma P; Quehenberger P; Gleixner K; Sperr WR Blood; 2021 Jan; 137(3):410-419. PubMed ID: 32766881 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]